HuGE Literature Finder
Records
1
-
3
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma. European urology 2016 Oct . Hsieh James J, Chen David, Wang Patricia I, Marker Mahtab, Redzematovic Almedina, Chen Ying-Bei, Selcuklu S Duygu, Weinhold Nils, Bouvier Nancy, Huberman Kety H, Bhanot Umesh, Chevinsky Michael S, Patel Parul, Pinciroli Patrizia, Won Helen H, You Daoqi, Viale Agnes, Lee William, Hakimi A Ari, Berger Michael F, Socci Nicholas D, Cheng Emily H, Knox Jennifer, Voss Martin H, Voi Maurizio, Motzer Robert |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nature genetics 2015 Jan 47 (1): 13-21. Durinck Steffen, Stawiski Eric W, Pavía-Jiménez Andrea, Modrusan Zora, Kapur Payal, Jaiswal Bijay S, Zhang Na, Toffessi-Tcheuyap Vanina, Nguyen Thong T, Pahuja Kanika Bajaj, Chen Ying-Jiun, Saleem Sadia, Chaudhuri Subhra, Heldens Sherry, Jackson Marlena, Peña-Llopis Samuel, Guillory Joseph, Toy Karen, Ha Connie, Harris Corissa J, Holloman Eboni, Hill Haley M, Stinson Jeremy, Rivers Celina Sanchez, Janakiraman Vasantharajan, Wang Weiru, Kinch Lisa N, Grishin Nick V, Haverty Peter M, Chow Bernard, Gehring Julian S, Reeder Jens, Pau Gregoire, Wu Thomas D, Margulis Vitaly, Lotan Yair, Sagalowsky Arthur, Pedrosa Ivan, de Sauvage Frederic J, Brugarolas James, Seshagiri Somasek |
Lifetime cancer risks in individuals with germline PTEN mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jan 18 (2): 400-7. Tan Min-Han, Mester Jessica L, Ngeow Joanne, Rybicki Lisa A, Orloff Mohammed S, Eng Char |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: